journal article·2024-12-13

Pea Protein Isolate-Based Nanofibers for Delivery of Clotrimazole

Kleopatra Kalouta, Mai Bay Stie, Valeria Vetri, Vito Foderà

ACS Applied Nano Materials· Volume 7· Issue 23
Publisher page

Abstract

A large part of the global population, including both immunocompromised and healthy individuals, suffers from fungal infections. The majority of current drug candidates for treating fungal infections exhibit poor water solubility, which hampers their permeability through biological barriers and limits their bioavailability. Here, we fabricated pea protein isolate (PPI)/poly(ethylene oxide) nanofibers (PPI/PEO nanofibers), with a high protein content [65% (w/w)] by waterborne electrospinning as an eco-friendly drug delivery system. X-ray diffraction results demonstrated that the solid-state properties of the individual components (PPI and PEO) were retained in the PPI/PEO nanofibers. We then encapsulated the poorly water-soluble drug, clotrimazole (CTZ), in the nanofibers (PPI/PEO/CTZ nanofibers), without heat treatment and/or use of an organic solvent or surfactant to presolubilize CTZ, generating an antifungal delivery system for topical administration. An in vitro study demonstrated that CTZ was successfully loaded in and released from the nanofibers. Additionally, the nanofibers were not toxic to HeLa cells. Finally, based on an antifungal disc agar diffusion study, CTZ-loaded nanofibers were shown to be effective against Candida albicans . The overall results demonstrate the potential of PPI-based nanofibers as a green platform for the generation of CTZ-loaded efficient drug delivery systems for antifungal treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Biochemical and Structural Characterization · Protein Hydrolysis and Bioactive Peptides · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 16, Palermo 90128, Italy

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark

Center for Biopharmaceuticals and Biobarriers in Drug Delivery, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark

Department of Physics and Chemistry, University of Palermo, Viale delle Scienze Ed. 18, Palermo 90128, Italy

Funding

Universit? degli Studi di Palermo · Novo Nordisk Fonden · Villum Fonden

References (62)

Show source-provided references
1. 10.3390/jof304005710.3390/jof3040057 ↗
2. WHO. WHO releases first-ever list of health-threatening fungi. 2022, https://www.who.int/news/item/25-10-2022-who-releases-first-ever-list-of-health-threatening-fungi (accessed June 08, 2024).
3. 10.1517/1742524080245718810.1517/17425240802457188 ↗
4. 10.3390/membranes1207068110.3390/membranes12070681 ↗
5. 10.3390/pharmaceutics1511253710.3390/pharmaceutics15112537 ↗
6. 10.3109/03639045.2011.59073110.3109/03639045.2011.590731 ↗
7. 10.1007/s13346-020-00830-410.1007/s13346-020-00830-4 ↗
8. National Center for Biotechnology Information. PubChem. Compound Summary for CID 2812, Clotrimazole. https://pubchem.ncbi.nlm.nih.gov/compound/Clotrimazole (accessed June 08, 2024).
9. 10.1016/j.heliyon.2020.e0466310.1016/j.heliyon.2020.e04663 ↗
10. 10.1016/j.ijpharm.2023.12328710.1016/j.ijpharm.2023.123287 ↗
11. 10.1016/j.jddst.2021.10248210.1016/j.jddst.2021.102482 ↗
12. 10.1016/j.msec.2017.05.03010.1016/j.msec.2017.05.030 ↗
13. Yaseen G. · 2021 · 19510.1016/B978-0-12-821885-3.00004-9 ↗
14. 10.3390/pharmaceutics1106026310.3390/pharmaceutics11060263 ↗
15. 10.1016/j.apmt.2016.09.01010.1016/j.apmt.2016.09.010 ↗
16. 10.1016/j.jconrel.2022.02.01610.1016/j.jconrel.2022.02.016 ↗
17. Arntfield S. D. · 2011 · 23310.1533/9780857093639.233 ↗
18. 10.1007/s11947-015-1589-610.1007/s11947-015-1589-6 ↗
19. 10.1111/1541-4337.1257310.1111/1541-4337.12573 ↗
20. 10.1016/j.ijpharm.2012.11.03310.1016/j.ijpharm.2012.11.033 ↗
21. 10.1016/j.ijpharm.2023.12270410.1016/j.ijpharm.2023.122704 ↗
22. 10.1016/j.foodchem.2022.13216310.1016/j.foodchem.2022.132163 ↗
23. 10.1016/j.ejpb.2017.09.01810.1016/j.ejpb.2017.09.018 ↗
24. 10.1016/j.jfoodeng.2020.11025810.1016/j.jfoodeng.2020.110258 ↗
25. 10.1016/j.ijbiomac.2023.12838310.1016/j.ijbiomac.2023.128383 ↗
26. 10.1016/j.foodhyd.2023.10954210.1016/j.foodhyd.2023.109542 ↗
27. 10.1007/s11947-019-02276-010.1007/s11947-019-02276-0 ↗
28. Roodbar Shojaei, T.; Hajalilou, A.; Tabatabaei, M.; Mobli, H.; Aghbashlo, M. Characterization and Evaluation of Nanofiber Materials; Springer International Publishing, 2019; pp 491–522.10.1007/978-3-319-53655-2_15 ↗
29. 10.3390/polym1512268410.3390/polym15122684 ↗
30. 10.1016/j.jconrel.2020.07.03810.1016/j.jconrel.2020.07.038 ↗
31. 10.1016/j.susmat.2022.e0051910.1016/j.susmat.2022.e00519 ↗
32. 10.1021/acs.molpharmaceut.0c0064210.1021/acs.molpharmaceut.0c00642 ↗
33. 10.1016/j.ijpharm.2018.12.05910.1016/j.ijpharm.2018.12.059 ↗
34. 10.3390/pharmaceutics1206055210.3390/pharmaceutics12060552 ↗
35. 10.1016/j.ijpharm.2017.04.04710.1016/j.ijpharm.2017.04.047 ↗
36. 10.1016/j.ejps.2019.01.02610.1016/j.ejps.2019.01.026 ↗
37. 10.1016/j.jare.2016.03.00910.1016/j.jare.2016.03.009 ↗
38. 10.1002/wnan.185910.1002/wnan.1859 ↗
39. 10.1016/j.jddst.2022.10376110.1016/j.jddst.2022.103761 ↗
40. 10.1021/acsanm.9b0255710.1021/acsanm.9b02557 ↗
41. 10.1021/acssuschemeng.4c0089510.1021/acssuschemeng.4c00895 ↗
42. 10.1001/jama.1936.0277014002000710.1001/jama.1936.02770140020007 ↗
43. 10.1097/00004770-200202000-0000410.1097/00004770-200202000-00004 ↗
44. 10.1016/j.msec.2018.09.03310.1016/j.msec.2018.09.033 ↗
45. 10.1016/j.ijbiomac.2019.11.21610.1016/j.ijbiomac.2019.11.216 ↗
46. 10.1016/j.polymertesting.2019.10621710.1016/j.polymertesting.2019.106217 ↗
47. 10.1016/j.foodchem.2018.11.07410.1016/j.foodchem.2018.11.074 ↗
48. Awei, P. Food & Nutrition Innovation Hub. Selection of types of pea protein for high-protein powdered beverages. https://www.roquette.com/innovation-hub/food/case-study/high-protein-powder-mixes-with-nutalys-s-plus (accessed June 08, 2024).
49. 10.1016/j.fhfh.2021.10001910.1016/j.fhfh.2021.100019 ↗
50. 10.1016/j.indcrop.2020.11309210.1016/j.indcrop.2020.113092 ↗
51. 10.1016/j.eurpolymj.2008.12.02410.1016/j.eurpolymj.2008.12.024 ↗
52. 10.1016/j.carbpol.2019.03.06110.1016/j.carbpol.2019.03.061 ↗
53. 10.1016/j.eurpolymj.2022.11139010.1016/j.eurpolymj.2022.111390 ↗
54. 10.1016/j.ijpharm.2019.11880910.1016/j.ijpharm.2019.118809 ↗
55. 10.1016/j.ejps.2016.01.01410.1016/j.ejps.2016.01.014 ↗
56. 10.3390/molecules2601023810.3390/molecules26010238 ↗
57. 10.1039/D1GC04252A10.1039/D1GC04252A ↗
58. 10.1016/j.ijpharm.2020.11981110.1016/j.ijpharm.2020.119811 ↗
59. 10.1208/s12249-010-9438-410.1208/s12249-010-9438-4 ↗
60. Roquette. NUTRALYS Family of Ingredients─Organic Isolate. https://www.roquette.com/plant-protein/ingredients/organic-isolate (accessed June 08, 2024).
61. CFR─Code of Federal Regulations. Title 21. 21CFR178.3750. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=178.3750 (accessed June 08, 2024).
62. 10.1007/s12602-023-10171-610.1007/s12602-023-10171-6 ↗